Env and Vpu Proteins of Human Immunodeficiency Virus Type 1 Are Produced from Multiple Bicistronic MRNAs

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1990 Nov 1

PMID 2214021

Citations 121

Authors

S Schwartz

B K Felber

E M Fenyo

G N Pavlakis

Affiliations

Soon will be listed here.

Abstract

Three size classes of human immunodeficiency virus type 1 (HIV-1) mRNAs are produced in infected cells: full-length, intermediate, and small. Here we report that the intermediate-size class of viral mRNAs is heterogeneous, consisting of at least 12 differentially spliced species. This group contains nine bicistronic mRNAs producing Env and Vpu and three mRNAs expressing only the first exon of tat. In the latter mRNAs, Env and Vpu expression is blocked by the presence of the upstream tat open reading frame. We conclude that internal initiation of translation is not the mechanism for generation of the bicistronic env mRNAs. Translation of HIV-1 mRNAs is consistent with the scanning mechanism in which Env is produced by leaky scanning from mRNAs that contain env as the second or third reading frame. Env and Vpu proteins are expressed from the same mRNAs and are coordinately regulated by Rev. This arrangement may reflect a requirement for coordinate expression of Vpu and Env.

Citing Articles

CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies.

Richard J, Sannier G, Zhu L, Prevost J, Marchitto L, Benlarbi M mBio. 2024; 15(11):e0182724.

PMID: 39373535 PMC: 11559134. DOI: 10.1128/mbio.01827-24.

Transcriptomic Signatures of Zika Virus Infection in Patients and a Cell Culture Model.

Berglund G, Lennon C, Badu P, Berglund J, Pager C Microorganisms. 2024; 12(7).

PMID: 39065267 PMC: 11278784. DOI: 10.3390/microorganisms12071499.

Zika virus infection in a cell culture model reflects the transcriptomic signatures in patients.

Berglund G, Lennon C, Badu P, Berglund J, Pager C bioRxiv. 2024; .

PMID: 38826459 PMC: 11142252. DOI: 10.1101/2024.05.25.595842.

Chronic HIV Transcription, Translation, and Persistent Inflammation.

Kilroy J, Leal A, Henderson A Viruses. 2024; 16(5).

PMID: 38793632 PMC: 11125830. DOI: 10.3390/v16050751.

Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 mRNA Production as Revealed by a Growth-Adaptive Mutation.

Koma T, Doi N, Le B, Kondo T, Ishizue M, Tokaji C Viruses. 2023; 15(12).

PMID: 38140666 PMC: 10747208. DOI: 10.3390/v15122424.

References

Felber B, Cladaras C, Copeland T, Pavlakis G . rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci U S A. 1989; 86(5):1495-9. PMC: 286723. DOI: 10.1073/pnas.86.5.1495. View

Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H . Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985; 230(4732):1350-4. DOI: 10.1126/science.2999980. View

Hammarskjold M, Heimer J, Hammarskjold B, Sangwan I, Albert L, Rekosh D . Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol. 1989; 63(5):1959-66. PMC: 250609. DOI: 10.1128/JVI.63.5.1959-1966.1989. View

Garcia J, Harrich D, Soultanakis E, Wu F, Mitsuyasu R, Gaynor R . Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 1989; 8(3):765-78. PMC: 400873. DOI: 10.1002/j.1460-2075.1989.tb03437.x. View

Selby M, Bain E, Luciw P, Peterlin B . Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 1989; 3(4):547-58. DOI: 10.1101/gad.3.4.547. View

Emerman M, Vazeux R, Peden K . The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell. 1989; 57(7):1155-65. DOI: 10.1016/0092-8674(89)90053-6. View

Terwilliger E, Cohen E, Lu Y, Sodroski J, Haseltine W . Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A. 1989; 86(13):5163-7. PMC: 297578. DOI: 10.1073/pnas.86.13.5163. View

Braddock M, Chambers A, Wilson W, Esnouf M, Adams S, Kingsman A . HIV-1 TAT "activates" presynthesized RNA in the nucleus. Cell. 1989; 58(2):269-79. DOI: 10.1016/0092-8674(89)90841-6. View

Strebel K, Klimkait T, Maldarelli F, Martin M . Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol. 1989; 63(9):3784-91. PMC: 250971. DOI: 10.1128/JVI.63.9.3784-3791.1989. View

10.

Salfeld J, Gottlinger H, Sia R, Park R, Sodroski J, Haseltine W . A tripartite HIV-1 tat-env-rev fusion protein. EMBO J. 1990; 9(3):965-70. PMC: 551759. DOI: 10.1002/j.1460-2075.1990.tb08195.x. View

11.

Benko D, Schwartz S, Pavlakis G, Felber B . A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol. 1990; 64(6):2505-18. PMC: 249426. DOI: 10.1128/JVI.64.6.2505-2518.1990. View

12.

Schwartz S, Felber B, Benko D, Fenyo E, Pavlakis G . Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol. 1990; 64(6):2519-29. PMC: 249427. DOI: 10.1128/JVI.64.6.2519-2529.1990. View

13.

Felber B, Drysdale C, Pavlakis G . Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. J Virol. 1990; 64(8):3734-41. PMC: 249668. DOI: 10.1128/JVI.64.8.3734-3741.1990. View

14.

Guatelli J, Gingeras T, Richman D . Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J Virol. 1990; 64(9):4093-8. PMC: 247871. DOI: 10.1128/JVI.64.9.4093-4098.1990. View

15.

Viglianti G, Sharma P, Mullins J . Simian immunodeficiency virus displays complex patterns of RNA splicing. J Virol. 1990; 64(9):4207-16. PMC: 247885. DOI: 10.1128/JVI.64.9.4207-4216.1990. View

16.

Arrigo S, Weitsman S, Zack J, Chen I . Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J Virol. 1990; 64(9):4585-8. PMC: 247934. DOI: 10.1128/JVI.64.9.4585-4588.1990. View

17.

Graham F, Van Der Eb A . A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2):456-67. DOI: 10.1016/0042-6822(73)90341-3. View

18.

Dayton A, Sodroski J, Rosen C, Goh W, Haseltine W . The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell. 1986; 44(6):941-7. DOI: 10.1016/0092-8674(86)90017-6. View

19.

Fisher A, Feinberg M, Josephs S, Harper M, Marselle L, Reyes G . The trans-activator gene of HTLV-III is essential for virus replication. Nature. 1986; 320(6060):367-71. DOI: 10.1038/320367a0. View

20.

Arya S, Gallo R . Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986; 83(7):2209-13. PMC: 323261. DOI: 10.1073/pnas.83.7.2209. View